Bellwyck GDUFA Registration

Bellwyck is on FDA list of GDUFA Registered Facilities

September 1, 2016 – Bellwyck Pharma Services, a leader in the supply of contract and clinical packaging solutions to the pharmaceutical industry is pleased to announce that it has self-identified with the United States Food and Drug Administration (USFDA) under the Generic Drug User Fee Amendment of 2012 (GDUFA). As required by GDUFA, the company has self-identified as a repackager and is now on FDA’s list of registered facilities for 2016.